- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00765882
Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks in Patients With Chronic Constipation
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Fase 3
Contatti e Sedi
Luoghi di studio
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V67 2K5
- Forest Investigative Site
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N 4A6
- Forest Investigative Site
-
Newmarket, Ontario, Canada, L3Y 7V1
- Forest Investigative Site
-
Ottawa, Ontario, Canada, K2c 3R2
- Forest Investigative Site
-
Sarnia, Ontario, Canada, N7T 4X3
- Forest Investigative Site 1
-
Sarnia, Ontario, Canada, N7T 4X3
- Forest Investigative Site 2
-
Sudbury, Ontario, Canada, P3E 1H5
- Forest Investigative Site
-
Toronto, Ontario, Canada, MCN 2V7
- Forest Investigative Site
-
-
-
-
Alabama
-
Birmingham, Alabama, Stati Uniti, 35205
- Forest Investigative Site
-
Birmingham, Alabama, Stati Uniti, 35215
- Forest Investigative Site
-
Huntsville, Alabama, Stati Uniti, 35801
- Forest Investigative Site
-
-
Arizona
-
Chandler, Arizona, Stati Uniti, 85225
- Forest Investigative Site
-
Mesa, Arizona, Stati Uniti, 85210
- Forest Investigative Site
-
Peoria, Arizona, Stati Uniti, 85381
- Forest Investigative Site
-
Phoenix, Arizona, Stati Uniti, 85012
- Forest Investigative Site
-
Scottsdale, Arizona, Stati Uniti, 85251
- Forest Investigative Site
-
Tucson, Arizona, Stati Uniti, 85741
- Forest Investigative Site
-
-
California
-
Burbank, California, Stati Uniti, 91505
- Forest Investigative Site
-
Encinitas, California, Stati Uniti, 92024
- Forest Investigative Site
-
Foothill Ranch, California, Stati Uniti, 92610
- Forest Investigative Site
-
Los Angeles, California, Stati Uniti, 90036
- Forest Investigative Site
-
Orange, California, Stati Uniti, 92869
- Forest Investigative Site
-
Westlake Village, California, Stati Uniti, 91361
- Forest Investigative Site
-
-
Colorado
-
Boulder, Colorado, Stati Uniti, 80304
- Forest Investigative Site
-
Colorado Springs, Colorado, Stati Uniti, 80909
- Forest Investigative Site
-
Denver, Colorado, Stati Uniti, 80205
- Forest Investigative Sites
-
Longmont, Colorado, Stati Uniti, 80501
- Forest Investigative Site
-
Wheat Ridge, Colorado, Stati Uniti, 80033
- Forest Investigative Site
-
-
Connecticut
-
Waterbury, Connecticut, Stati Uniti, 06708
- Forest Investigative Site
-
-
Florida
-
Boca Raton, Florida, Stati Uniti, 33486
- Forest Investigative Site
-
Bradenton, Florida, Stati Uniti, 34203
- Forest Investigative Site
-
Brooksville, Florida, Stati Uniti, 34601
- Forest Investigative Site
-
Ft. Myers, Florida, Stati Uniti, 33916
- Forest Investigative Site
-
Jupiter, Florida, Stati Uniti, 33458
- Forest Investigative Site
-
Kissimmee, Florida, Stati Uniti, 34741
- Forest Investigative Site
-
Miami, Florida, Stati Uniti, 33143
- Forest Investigative Site
-
Ocala, Florida, Stati Uniti, 34471
- Forest Investigative Site
-
Orlando, Florida, Stati Uniti, 32806
- Forest Investigative Site
-
Panama City, Florida, Stati Uniti, 32405
- Forest Investigative Site
-
Pembroke Pines, Florida, Stati Uniti, 33024
- Forest Investigative Site
-
St. Petersburg, Florida, Stati Uniti, 33709
- Forest Investigative Site
-
Tampa, Florida, Stati Uniti, 33606
- Forest Investigative Site
-
Trinity, Florida, Stati Uniti, 34655
- Forest Investigative Site
-
Zephyrhills, Florida, Stati Uniti, 33542
- Forest Investigative Site
-
-
Georgia
-
Atlanta, Georgia, Stati Uniti, 30342
- Forest Investigative Site
-
Marietta, Georgia, Stati Uniti, 30060
- Forest Investigative Site
-
Marietta, Georgia, Stati Uniti, 30067
- Forest Investigative Site
-
Stockbridge, Georgia, Stati Uniti, 30281
- Forest Investigative Site
-
Woodstock, Georgia, Stati Uniti, 30189
- Forest Investigative Site
-
-
Idaho
-
Idaho Falls, Idaho, Stati Uniti, 83404
- Forest Investigative Site
-
-
Illinois
-
Rockford, Illinois, Stati Uniti, 61107
- Forest Investigative Site
-
-
Indiana
-
Elkhart, Indiana, Stati Uniti, 46514
- Forest Investigative Site
-
Evansville, Indiana, Stati Uniti, 47714
- Forest Investigative Site
-
Indianapolis, Indiana, Stati Uniti, 46237
- Forest Investigative Site
-
Indianapolis, Indiana, Stati Uniti, 46254
- Forest Investigative Site
-
-
Iowa
-
Iowa City, Iowa, Stati Uniti, 52242
- Forest Investigative Site
-
-
Kansas
-
Arkansas City, Kansas, Stati Uniti, 67005
- Forest Investigative Site
-
Newton, Kansas, Stati Uniti, 67114
- Forest Investigative Site
-
Wichita, Kansas, Stati Uniti, 67205
- Forest Investigative Site
-
Wichita, Kansas, Stati Uniti, 67207
- Forest Investigative Site
-
-
Kentucky
-
Lexington, Kentucky, Stati Uniti, 40509
- Forest Investigative Site
-
Madisonville, Kentucky, Stati Uniti, 42431
- Forest Investigative Site
-
-
Maryland
-
Chevy Chase, Maryland, Stati Uniti, 20815
- Forest Investigative Site
-
Hagerstown, Maryland, Stati Uniti, 21742
- Forest Investigative Site
-
Lutherville, Maryland, Stati Uniti, 21093
- Forest Investigative Site
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02135
- Forest Investigative Site
-
-
Minnesota
-
Chaska, Minnesota, Stati Uniti, 55318
- Forest Investigative Site
-
-
Missouri
-
St. Louis, Missouri, Stati Uniti, 63110
- Forest Investigative Site
-
St. Louis, Missouri, Stati Uniti, 63128
- Forest Investigative Site
-
-
New Jersey
-
Vineland, New Jersey, Stati Uniti, 08360
- Forest Investigative Site
-
-
New Mexico
-
Albuquerque, New Mexico, Stati Uniti, 87106
- Forest Investigative Site
-
-
New York
-
Brooklyn, New York, Stati Uniti, 11214
- Forest Investigative Site
-
Great Neck, New York, Stati Uniti, 11021
- Forest Investigative Site
-
Great Neck, New York, Stati Uniti, 11023
- Forest Investigative Site
-
-
North Carolina
-
Fayetteville, North Carolina, Stati Uniti, 28304
- Forest Investigative Site
-
Greensboro, North Carolina, Stati Uniti, 27403
- Forest Investigative Site
-
Hickory, North Carolina, Stati Uniti, 28601
- Forest Investigative Site
-
Raleigh, North Carolina, Stati Uniti, 27612
- Forest Investigative Site
-
Wilmington, North Carolina, Stati Uniti, 28401
- Forest Investigative Site
-
Winston-Salem, North Carolina, Stati Uniti, 27103
- Forest Investigative Site
-
-
North Dakota
-
Bismark, North Dakota, Stati Uniti, 58501
- Forest Investigative Site
-
-
Ohio
-
Akron, Ohio, Stati Uniti, 44302
- Forest Investigative Site
-
Cincinnati, Ohio, Stati Uniti, 45219
- Forest Investigative Site
-
Cleveland, Ohio, Stati Uniti, 44122
- Forest Investigative Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Stati Uniti, 73104
- Forest Investigative Site
-
Tulsa, Oklahoma, Stati Uniti, 74135
- Forest Investigative Site
-
-
Pennsylvania
-
Bensalem, Pennsylvania, Stati Uniti, 19020
- Forest Investigative Site
-
Pittsburgh, Pennsylvania, Stati Uniti, 15206
- Forest Investigative Site
-
-
South Carolina
-
Greenville, South Carolina, Stati Uniti, 29615
- Forest Investigative Site
-
Greer, South Carolina, Stati Uniti, 29651
- Forest Investigative Site
-
-
Tennessee
-
Nashville, Tennessee, Stati Uniti, 37205
- Forest Investigative Site
-
-
Texas
-
Austin, Texas, Stati Uniti, 78705
- Forest Investigative Site
-
Dallas, Texas, Stati Uniti, 75234
- Forest Investigative Site
-
Houston, Texas, Stati Uniti, 77090
- Forest Investigative Site
-
Lake Jackson, Texas, Stati Uniti, 77566
- Forest Investigative Site
-
San Antonio, Texas, Stati Uniti, 78229
- Forest Investigative Site
-
San Antonio, Texas, Stati Uniti, 78209
- Forest Investigative Site
-
-
Utah
-
Salt Lake City, Utah, Stati Uniti, 84102
- Forest Investigative Site
-
-
Virginia
-
Charlottesville, Virginia, Stati Uniti, 22911
- Forest Investigative Site
-
Christianburg, Virginia, Stati Uniti, 24073
- Forest Investigative Site
-
Newport News, Virginia, Stati Uniti, 23606
- Forest Investigative Site
-
Norfolk, Virginia, Stati Uniti, 23502
- Forest Investigative Site
-
Norfolk, Virginia, Stati Uniti, 23507
- Forest Investigative Site
-
Richmond, Virginia, Stati Uniti, 23294
- Forest Investigative Site
-
-
Washington
-
Bellevue, Washington, Stati Uniti, 98402
- Forest Investigative Site
-
Lakewood, Washington, Stati Uniti, 98499
- Forest Investigative Site
-
Wenatchee, Washington, Stati Uniti, 98801
- Forest Investigative Site
-
-
Wisconsin
-
Milwaukee, Wisconsin, Stati Uniti, 53209
- Forest Investigative Site
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Patient has completed a colonoscopy according to the AGA criteria, with no clinically significant findings
- Patient has successfully completed protocol procedures (with no clinically significant findings): physical exam, 12-lead ECG, or clinical laboratory tests
- Patient meets protocol criteria for CC: reports < 3 bowel movements per week and reports straining, lumpy or hard stools, and/or sensation of incomplete evacuation during > 25% of BMs
- Patient demonstrates continued chronic constipation through Pretreatment Period
- Patient is compliant with IVRS
Exclusion Criteria:
- Patient has history of loose or watery stools
- Patient has symptoms of or been diagnosed with Irritable Bowel Syndrome (IBS)
- Patient has a structural abnormality of the gastrointestinal (GI) tract or a disease or condition that can affect GI motility
- Patient has any protocol-excluded or clinically significant medical or surgical history that could confound the study assessments
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Quadruplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: 1
Linaclotide 290 micrograms
|
Orale, una volta al giorno ogni mattina almeno 30 minuti prima di colazione per tutta la durata dello studio
|
|
Sperimentale: 2
Linaclotide 145 micrograms
|
Oral, once daily each morning at least 30 minutes before breakfast for the duration of the study
|
|
Comparatore placebo: 3
Matching placebo
|
Oral, once daily each morning at least 30 minutes before breakfast for the duration of the study
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Complete Spontaneous Bowel Movement (CSBM) Overall Responder
Lasso di tempo: Change from Baseline to Week 12
|
A 12-week CSBM overall responders was defined as a patient who for at least 9 of the 12 weeks of the treatment period had a CSBM weekly frequency rate that was 3 or greater and increased by 1 or more from baseline. A CSBM was defined as a spontaneous bowel movement (SBM) that was associated with a sense of complete evacuation. An SBM was defined as a bowel movement (BM) that occurred in the absence of laxative, enema, or suppository use on either the calendar day of the BM or the calendar day before the BM. |
Change from Baseline to Week 12
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
12-week Complete Spontaneous Bowel Movement (CSBM) Frequency Rate
Lasso di tempo: Change from Baseline to Week 12
|
The number of CSBMs per week.
|
Change from Baseline to Week 12
|
|
12-Week Spontaneous Bowel Movement (SBM) Frequency Rate
Lasso di tempo: Change from Baseline to Week 12
|
A patient's 12-week spontaneous bowel movement (SBM) frequency rate was the number of SBMs per week calculated over the 12-weeks of the treatment period.
|
Change from Baseline to Week 12
|
|
12-Week Stool Consistency
Lasso di tempo: Change from Baseline to Week 12
|
The consistency of each BM was assessed using the 7-point Bristol Stool Form Scale:
|
Change from Baseline to Week 12
|
|
12-Week Severity of Straining
Lasso di tempo: Change from Baseline to Week 12
|
Straining is measured on a 5-point scale, where a value of 1 is "not at all" and a value of 5 is "an extreme amount.
|
Change from Baseline to Week 12
|
|
12-Week Abdominal Discomfort
Lasso di tempo: Change from Baseline to Week 12
|
Abdominal discomfort is based on a 5-point scale where a value of l is "none" and a value of 5 is "very severe."
|
Change from Baseline to Week 12
|
|
12-Week Bloating
Lasso di tempo: Change from Baseline to Week 12
|
Bloating was based on a 5-point scale where a value of l is "none" and a value of 5 is "very severe".
|
Change from Baseline to Week 12
|
|
12-Week Constipation Severity
Lasso di tempo: Change from Baseline to Week 12
|
Constipation severity was based on a 5-point ordinal scale where a value of l is "none" and a value of 5 is "very severe".
|
Change from Baseline to Week 12
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Direttore dello studio: Paul F.C. Eng, PhD, Forest Laboratories
Pubblicazioni e link utili
Pubblicazioni generali
- Chang L, Lembo AJ, Lavins BJ, Shiff SJ, Hao X, Chickering JG, Jia XD, Currie MG, Kurtz CB, Johnston JM. The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials. Aliment Pharmacol Ther. 2014 Dec;40(11-12):1302-12. doi: 10.1111/apt.12985. Epub 2014 Oct 13.
- Lembo AJ, Schneier HA, Shiff SJ, Kurtz CB, MacDougall JE, Jia XD, Shao JZ, Lavins BJ, Currie MG, Fitch DA, Jeglinski BI, Eng P, Fox SM, Johnston JM. Two randomized trials of linaclotide for chronic constipation. N Engl J Med. 2011 Aug 11;365(6):527-36. doi: 10.1056/NEJMoa1010863.
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- LIN-MD-01
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Costipazione cronica
-
Third Affiliated Hospital, Sun Yat-Sen UniversityAttivo, non reclutanteInsufficienza epatica acuta su Chronic (ACLF)Cina
-
Yaqrit LtdKing's College Hospital NHS Trust; University College, London; Royal Free Hospital... e altri collaboratoriNon ancora reclutamentoCirrosi epatica | Insufficienza epatica acuta su Chronic (ACLF)
-
Institute of Liver and Biliary Sciences, IndiaNon ancora reclutamentoInsufficienza epatica acuta su Chronic (ACLF)
-
Institute of Liver and Biliary Sciences, IndiaNon ancora reclutamentoInsufficienza epatica acuta su Chronic (ACLF)
-
Qilu Hospital of Shandong UniversityAttivo, non reclutanteInsufficienza epatica acuta su Chronic correlata all'HBVCina
-
Qilu Hospital of Shandong UniversityReclutamentoPaesaggio a cellule singolo di pazienti con insufficienza epatica acuta su cronica correlata all'HBVInsufficienza epatica acuta su Chronic correlata all'HBVCina
-
Qilu Hospital of Shandong UniversityReclutamentoCirrosi epatica HBV correlata | HBV (virus dell'epatite B) | Insufficienza epatica acuta su Chronic correlata all'HBVCina
Prove cliniche su Linaclotide 290 microgrammi
-
Fudan UniversityReclutamentoCancro polmonare a piccole cellule in stadio limitatoCina
-
BeiGeneTerminatoCancro alla prostata metastatico resistente alla castrazione (mCRPC) | Carenza di ricombinazione omologa (HRD)Stati Uniti, Australia, Porto Rico, Spagna
-
Australia New Zealand Gynaecological Oncology GroupBeiGeneRitirato
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Shanghai Runshi Pharmaceutical Technology Co., LtdReclutamento
-
M.D. Anderson Cancer CenterCompletatoNeoplasia solida maligna avanzata | Neoplasia solida maligna refrattariaStati Uniti
-
Sun Yat-sen UniversityReclutamentoCancro alla prostata metastatico resistente alla castrazioneCina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); BeiGeneCompletatoGlioblastoma ricorrente | Glioma ricorrente di grado III dell'OMS | Glioma ricorrente di grado II dell'OMS | Mutazione IDH1 | Mutazione IDH2Stati Uniti
-
Claes-Göran ÖstensonAraim Pharmaceuticals, Inc.SconosciutoTolleranza al glucosio compromessa | Alterata glicemia a digiuno | Diabete di tipo 2Svezia
-
Araim Pharmaceuticals, Inc.CompletatoNeuropatia della sarcoidosiStati Uniti, Olanda
-
BeiGeneMyriad Genetic Laboratories, Inc.CompletatoTumori solidiStati Uniti, Spagna, Regno Unito, Francia, Australia, Nuova Zelanda